Has Edward Dauterive, MD received payments from drug or device companies?

Yes. Drug and device makers reported $62,909 in general payments to Edward Dauterive, MD across 1,072 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Edward Dauterive, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Edward Dauterive, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Edward Dauterive, MD

Gastroenterology · Slidell, LANPI 1720302730

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 47 manufacturers reported payments, led by Nestle Healthcare Nutrition Inc. at 42.6% of the total. Reporting peaked in 2021 at $28,850 and has fallen 88.2% since, to $3,398 in 2025. Among gastroenterology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$62,909in general payments, 2019–2025

Across 1,072 payments — averaging $58.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nestle Healthcare Nutrition Inc.$27K
AbbVie$14K
US Endoscopy$10K
Takeda Pharmaceuticals U.S.A., Inc.$1K
Gilead$1K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
plus $8K from 41 others

What the payments were for

Consulting fees$9,00014%
Speaking & faculty fees$33,25053%
Travel & lodging$2,7614%
Food & beverage$17,79528%
Education$1030%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nestle Healthcare Nutrition Inc.	32	$26,795
AbbVie(2 entities)	394	$14,398
US Endoscopy	6	$9,883
Takeda Pharmaceuticals U.S.A., Inc.	102	$1,289
Gilead	54	$1,281
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	83	$1,134
Johnson & Johnson(2 entities)	83	$1,096
Medtronic(2 entities)	10	$971
Bristol Myers Squibb	56	$897
Pfizer	39	$610
Conmed Corporation	9	$478
Boston Scientific	10	$403
Intercept Pharmaceuticals, Inc.	21	$377
Merck	24	$373
Sanofi	12	$259
Regeneron Healthcare Solutions, Inc.	7	$250
QOL Medical, LLC	14	$234
Lilly USA, LLC	8	$221
Ironwood Pharmaceuticals, Inc	13	$205
Ipsen Biopharmaceuticals, Inc	5	$202
Ardelyx, Inc.	9	$172
Celltrion USA Inc.	9	$157
Shionogi Inc	7	$112
Daiichi Sankyo Inc.	6	$103
Micro-tech Endoscopy USA, Inc.	3	$96
Madrigal Pharmaceuticals	1	$96
Phathom Pharmaceuticals, Inc.	8	$88
Steris Corporation	3	$87
Romark Laboratories, LC	6	$77
Amgen	3	$60
Evoke Pharma, Inc.	4	$59
UCB, Inc.	4	$58
Aimmune Therapeutics, Inc.	3	$52
Organon	4	$43
Shire North American Group Inc	3	$40
Braintree Laboratories, Inc.	2	$39
Axonics, Inc.	2	$35
Ferring Pharmaceuticals Inc.	2	$30
Redhill Biopharma Inc.	2	$24
Pharmacosmos Therapeutics Inc.	2	$23
Intra-sana Laboratories	1	$21
Biocon Biologics Inc	1	$17
Dova Pharmaceuticals	1	$15
Exact Sciences	1	$14
Endogastric Solutions, Inc	1	$14
Echosens North America, Inc.	1	$11
Vivus LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$62,909 in reported general payments places this provider in the 90th percentile of 254 gastroenterology providers in Louisiana.

See all gastroenterology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$196,711

Medicare patients

457

Services billed

4,788

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CreonLipase/Protease/Amylase	22	$185,039
ZenpepLipase/Protease/Amylase	19	$166,035
XifaxanRifaximin	49	$138,456
IbsrelaTenapanor Hcl	28	$60,915
LinzessLinaclotide	42	$41,527
ClenpiqSod Picosulf/Mag Ox/Citric Ac	65	$10,331
Sucralfate	59	$5,426
Pantoprazole Sodium	390	$4,742
SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag	24	$2,984
Omeprazole	38	$755
Ondansetron OdtOndansetron	40	$660
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine	31	$645
Dicyclomine Hcl	35	$563
Esomeprazole Magnesium	15	$448
Famotidine	27	$284

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieCreon, Linzess	$14,398	$226,56664 claims
Aimmune Therapeutics, Inc.Zenpep	$52	$166,03519 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan	$1,134	$138,45649 claims
Ardelyx, Inc.Ibsrela	$172	$60,91528 claims
Ferring Pharmaceuticals Inc.Clenpiq	$30	$10,33165 claims
Braintree Laboratories, Inc.Suflave	$39	$2,98424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 254 gastroenterology providers in Louisiana.